Iridex's IQ laser systems cleared by FDA
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for Iridex's IQ family of laser systems. It includes the IQ 532 (green spectrum), IQ 577 (yellow), IQ 630-670 (red) and IQ 810 (infrared) systems, which are used for a wide range of applications including ophthalmology, otolaryngology (ear, nose and throat) and dermatology. For example, the 532nm laser can correct certain types of hearing loss, while 810nm lasers can treat glaucoma. Mountain View, California-based Iridex will launch the IQ 577 yellow light laser first, which it says provides a wavelength and technology that is not commercially available from any of its competitors. It can deliver light in a continuous wave or MicroPulse, tissue-sparing, mode.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.